CELLMED 2023 KCI Impact Factor : 0.02
-
pISSN : 3022-6805 / eISSN : 3022-6791
- https://journal.kci.go.kr/cellmed
pISSN : 3022-6805 / eISSN : 3022-6791
The CellMed Orthocellular Medicine and Pharmaceutical Association (COMPA) aims for the development of medicine combined with Humanities through human agony, rich experience and wisdom about medicine based on the spirit of humanity. Since it has established in 2010 by a number of renowned scholars, it has announced important discoveries in all medical fields including classical medicine, pathology, clinical medicine, botany, prescription medicine, pharmacology, physiology, pathology, preventive medicine, nutrition and oriental medicine for the purpose of developing humanities medicine.
Under the OCNT (Ortho-Cellular Nutrition Therapy) theory, COMPA has developed a level of awareness and analyzed the causes of common serious health problems such as chronic diseases in order to find fundamental solutions for these problems by utilizing active plant nutrition, phytochemicals and flavonoids. COMPA plays an active role in promoting the exchange of academic achievements of worldwide scholars who are interested in this field for the purpose of developing humanitas medicine by submitting their great achievements through a CellMed Journal, formerly TANG [HUMANITAS MEDICINE] operated by COMPA
We hope our spirit can contribute to the development of current medicine insubstantial ways. We also hope our spirit will build the identity of all medicine. Fair criticism and advice will be greatly appreciated. We hope for an eco-friendly and human-centered medicine to develop the quality of life and contribute to the future of a healthier Humanity